A detailed history of Voya Financial Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Voya Financial Advisors, Inc. holds 1,777 shares of LLY stock, worth $1.46 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,777
Previous 1,726 2.95%
Holding current value
$1.46 Million
Previous $1.34 Million 19.82%
% of portfolio
0.18%
Previous 0.15%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $36,968 - $46,361
51 Added 2.95%
1,777 $1.61 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $119,624 - $160,040
-202 Reduced 10.48%
1,726 $1.34 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $76,152 - $89,773
145 Added 8.13%
1,928 $1.12 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $5,216 - $7,191
-12 Reduced 0.67%
1,783 $957,000
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $47,349 - $63,312
135 Added 8.13%
1,795 $841,000
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $16,152 - $18,970
52 Added 3.23%
1,660 $570,000
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $63,988 - $74,559
199 Added 14.12%
1,608 $588,000
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $23,718 - $27,029
80 Added 6.02%
1,409 $465,000
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $26,479 - $31,090
95 Added 7.7%
1,329 $429,000
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $289,607 - $359,908
1,234 New
1,234 $358,000
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $1.16 Million - $1.5 Million
-6,426 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $99,577 - $128,908
-606 Reduced 8.62%
6,426 $1.19 Million
Q4 2020

Mar 05, 2021

SELL
$130.46 - $172.63 $35,615 - $47,127
-273 Reduced 3.74%
7,032 $1.17 Million
Q3 2020

Nov 16, 2020

SELL
$146.22 - $169.13 $417,311 - $482,697
-2,854 Reduced 28.09%
7,305 $1.07 Million
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $393,980 - $474,151
-2,888 Reduced 22.14%
10,159 $1.65 Million
Q1 2020

May 15, 2020

BUY
$119.05 - $147.35 $51,786 - $64,097
435 Added 3.45%
13,047 $1.81 Million
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $47,793 - $59,196
-447 Reduced 3.42%
12,612 $1.66 Million
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $175,135 - $190,502
1,640 Added 14.36%
13,059 $1.47 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $148,458 - $173,288
1,340 Added 13.29%
11,419 $1.27 Million
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $64,448 - $75,860
579 Added 6.09%
10,079 $1.3 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $86,732 - $97,166
819 Added 9.43%
9,500 $1.09 Million
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $184,856 - $231,038
2,153 Added 32.98%
8,681 $926,000
Q2 2018

Aug 14, 2018

BUY
$75.7 - $86.88 $78,122 - $89,660
1,032 Added 18.78%
6,528 $558,000
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $3,042 - $3,591
41 Added 0.75%
5,496 $423,000
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $11,225 - $12,040
137 Added 2.58%
5,455 $464,000
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $409,858 - $454,901
5,318
5,318 $452,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $778B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Voya Financial Advisors, Inc. Portfolio

Follow Voya Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Voya Financial Advisors, Inc. with notifications on news.